RenovoRx Company Insiders

RenovoRx Management Team Effectiveness

The company has return on total asset (ROA) of (0.6839) % which means that it has lost $0.6839 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4661) %, meaning that it created substantial loss on money invested by shareholders. RenovoRx's management efficiency ratios could be used to measure how well RenovoRx manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.31 in 2026. Return On Capital Employed is likely to drop to -2.13 in 2026. Total Current Liabilities is likely to drop to about 1.3 M in 2026. Liabilities And Stockholders Equity is likely to drop to about 6.8 M in 2026Common Stock Shares Outstanding is likely to drop to about 21 M in 2026. Net Loss is likely to drop to about (9.3 M) in 2026RenovoRx owns a total of 36.65 Million outstanding shares. RenovoRx holds 4.63 pct. of its outstanding shares held by insiders and 20.2 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it. Dividend Paid And Capex Coverage Ratio is likely to drop to -918.2 in 2026. Common Stock Shares Outstanding is likely to drop to about 21 M in 2026. Net Loss is likely to drop to about (9.3 M) in 2026.

RenovoRx Workforce Comparison

RenovoRx Insider Trading

RenovoRx Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as RenovoRx often depends on how effective the management is. RenovoRx management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of RenovoRx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the RenovoRx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in RenovoRx's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of RenovoRx. Check RenovoRx's Beneish M Score to see the likelihood of RenovoRx's management manipulating its earnings.

When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.